Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unasyn vs. Ampicillin/Gentamicin for Intrapartum Chorioamnionitis
NCT00879190Phase 3Completed
- Sponsor
- Stanford University
- Start
- May 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ampicillin + sulbactam in chorioamnionitis (IAI) (2 arms), sponsored by Stanford University. Primary endpoint: Resolution of Fever by 24 Hours Postpartum. Started May 2009; status: completed.
02
Drugs
ampicillin + sulbactam
03
Conditions
chorioamnionitis (IAI)
Beyond the preview
Go deeper on NCT00879190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879190.